Short Story

A Short Story

Starting with a desire to continuously study medicine and seek knowledge through research, Prof. DR. Dr. Sri Rezeki Hadinegoro, Sp.A(K), and other pediatric infectious disease specialists collaborated to conduct clinical trials in 2011. Since then, enthusiasm for clinical trials has steadily increased. After conducting several COVID-19 research studies, the demand for clinical trials grew significantly. To facilitate researchers, the Infectious Disease Division in the Department of Pediatrics, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital transformed the research group into the Pediatrics Tropical Disease and Infection Research and Innovation (Petridish) Faculty of Medicine Universitas Indonesia on November 19, 2023. Petridish-FKUI was established to serve as a platform for the development of clinical trials for vaccines and medicines, as well as the epidemiological study of infectious diseases.


  1. CYD

    Principal Investigator: Prof. Dr. dr. Sri Rezeki Hadinegoro, Sp. A(K)
    Sponsor: Sanofi Pasteur

  2. ZF2001

    Principal Investigator: Prof. Dr. dr. Hindra Irawan Satari, Sp.A(K), MTropPaed
    Sponsor: Anhui Zhifei Longcom Biopharmaceutical Co., Ltd.

  3. BCOV

    Principal Investigator: Dr. Eddy Fadlyana, dr., Sp.A(K)., Mkes
    Co-Principal Investigator:
    1. Site Jakarta: dr. Nina Dwi Putri, Sp.A(K), M.Sc(TropPaed)
    2. Site Bandung: Dr. Djatnika Setiabudi, dr., Sp.A(K)
    Sponsor: The National Institute of Health Research and Development

  4. MBCOV

    Principal Investigator: dr. Nina Dwi Putri, Sp.A(K), M.Sc(TropPaed)
    Sponsor: Indonesian Ministry of Health

  5. TB Epid

    Principal Investigator: Prof. Dr. dr. Sri Rezeki Hadinegoro, Sp. A(K)
    Sponsor: Bill & Melinda Gates Medical Research Institute

  6. TB Vaksin

    Principal Investigator: Prof. Dr. dr. Sri Rezeki Hadinegoro, Sp. A(K)
    Sponsor: Bill & Melinda Gates Medical Research Institute

What Inspires Us

INNOVATION AND COMMUNITY IMPACTS

For over a decade, our organization has been dedicated to advancing clinical research, with a primary focus on infectious and tropical diseases. Our commitment to this vital field, driven by a team of experts, has allowed us to make a significant impact on global community health.

  • Experience and Expertise

    With 12 years of experience, we specialize in infectious and tropical disease clinical trials, leveraging our deep expertise.

  • Dedicated Team

    Our team, led by infectious disease experts, ensures the precision and effectiveness of our research.

  • Global Reach

    Our influence extends nationally and internationally, demonstrating our substantial global presence.

  • Research Objectives

    We prioritize accurate, impactful research to improve global community health and address pressing diseases.

  • Innovation and Community Focus

    We are committed to innovation and a community-centric approach, enhancing the experience for participants and site teams.

  • Health Equity

    Our aim is to increase research outcomes, promoting health equity by benefiting diverse populations.

Our Teams

Partners

Kemenkes RSCM FKUI Sanofi Prodia ISARIC Sinovac MCRI Bill And Melinda Gates Medical Research Institute Anhui Zhifei Biofarma Etana Biotech INA Respond Walvax BRIN Diarc FKUI LMK UI University of Melbourne MSA Kargo World Courier Lembaga Pengelola Dana Pendidikan CanSino Biologics Tigermed